
2ndVote Life Neutral Plus ETF
LYFE
Updated: 23/09/2026, 01:40:47
No historical data available
This actively managed exchange-traded fund (ETF) primarily invests its capital, potentially including borrowed funds for investment, in the equity securities of large and mid-capitalization companies. These companies are either based in the U.S. or have their shares principally traded on U.S. securities markets. A key component of its strategy is that these companies must align with the fund's specific pro-life social criteria. The selection of these stocks is carried out through a combination of fundamental security analysis and the application of its own proprietary social scoring system.
No summaries found.
- Share price
- $33.58
- Market cap
- $6.69B
- Exchange
- CBOE
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 17/11/2020
- Beta
- 0
- Last dividend
- $0.00
- Day range
- $33.58 – $33.64
- 52-week range
- $28.84 – $34.38
- 1-day performance
- -0.09%
- 1-year performance
- 16.45%
- Current drawdown (1Y)
- -2.31%
- CIK
- 0001811168
- CUSIP
- 81386P108
- ISIN
- US81386P1084
- Created
- 07/12/2025, 05:08:34
- Last update
- 23/09/2026, 01:40:47
Track 2ndVote Life Neutral Plus ETF with an AI analyst
See which prediction-market events move LYFE, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.